Testing effectiveness (Phase 2)Study completedNCT01983969What this trial is testingAza-SAHA-GBM With AutoSCT for Refractory LymphomaWho this might be right forAdvanced CancersLymphoma M.D. Anderson Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00867529What this trial is testingRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT06093841What this trial is testingRelmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHLWho this might be right forLymphoma, Large B-Cell, DiffuseFollicular Lymphoma Grade 3BHigh-grade B-cell Lymphoma+1 more Shanghai Ming Ju Biotechnology Co., Ltd. 46
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT03575351What this trial is testingCompare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin LymphomasWho this might be right forLymphoma, Non-Hodgkin Celgene 184
Not applicableActive Not RecruitingNCT02256137What this trial is testingA Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood CancerWho this might be right forAcute Lymphoblastic LeukemiaBrain TumorHodgkin Lymphoma St. Jude Children's Research Hospital 1,564
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06580002What this trial is testingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialWho this might be right forBreast CancerSarcomaGastric Cancer+19 more University of California, Irvine 75
Testing effectiveness (Phase 2)UnknownNCT04948788What this trial is testingSHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forRecurrent and Refractory B-cell Non-Hodgkin's Lymphoma Jiangsu HengRui Medicine Co., Ltd. 102
Testing effectiveness (Phase 2)Study completedNCT01453205What this trial is testingA Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-Cell Lymphoma MedImmune LLC 187
Testing effectiveness (Phase 2)Study completedNCT00179673What this trial is testingLenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins Lymphoma Celgene 43
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT00004031What this trial is testingSWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 397
Testing effectiveness (Phase 2)Study completedNCT02398240What this trial is testingBrentuximab for Newly Diagnosed Hodgkin DiseaseWho this might be right forHodgkin Lymphoma Mitchell Cairo 40
Early research (Phase 1)Ended earlyNCT03465540What this trial is testingSafety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesWho this might be right forMultiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more Amgen 24
Testing effectiveness (Phase 2)Study completedNCT01045889What this trial is testingHigh Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High RiskWho this might be right forHIV-related LymphomaHIV Infections Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 27
Testing effectiveness (Phase 2)Ended earlyNCT00126243What this trial is testingEfficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaWho this might be right forAIDS Related Lymphoma French National Agency for Research on AIDS and Viral Hepatitis 60
Early research (Phase 1)Study completedNCT01342289What this trial is testingShorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation CyclophosphamideWho this might be right forHodgkin's LymphomaLeukemiaMyelodysplastic Syndrome(MDS)+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127
Testing effectiveness (Phase 2)Ended earlyNCT04161118What this trial is testingTisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forNon Hodgkin Lymphoma University of Cologne 3